🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05715710
Recruiting Observational

Correlation Between Deep Medullary Veins and Cognitive Dysfunction in Cerebral Small Vessel Disease

NCT05715710 · tracked via the Priya Life Science China tracker
Sponsor
Zigong No.1 Peoples Hospital
Phase
Observational
Started
2022-01-01
Last updated
2025-01-28

Condition(s) studied

Cerebral Small Vessel Disease

Study summary

This study aims to obtain the characteristics of cognitive impairment and imaging characteristics of patients with Cerebral small vessel disease (CSVD) through comprehensive and standardized neuropsychological assessment and multimodal imaging examination. The focus is to obtain the characteristics of cognitive impairment and imaging characteristics of patients with CSVD through 3.0T MRI SWI sequence. deep medullary veins (DMVs) were measured. To compare the demographic data, hematological indexes, imaging scores and the number of DMVs between CSVD groups with and without cognitive impairment, and to explore the correlation between deep medullary veins and cognitive dysfunction in cerebral small vessel disease.

Eligibility

Sex
ALL
Min age
50 Years
Max age
85 Years
Healthy volunteers
Accepted
1. Inclusion Criteria 1. Age 50 \~ 85 years old. 2. The diagnostic criteria of CSVD patients with cerebral small vessel diseases should be in accordance with the 2015 Chinese Consensus on the diagnosis and treatment of cerebral small vessel Diseases formulated and recommended by the Cerebrovascular Division of Chinese Society of Neurology, Chinese Medical Association. MRI examination revealed the presence of one or more of the major imaging features of CSVD as proposed by the 2013 International Standards Reporting Group on Neuroimaging of Vascular Changes. 3. No large vessel stenosis (stenosis rate \> 50%) was found after head and neck vascular examination (CTA, MRA, DSA or TCD combined with carotid ultrasound). 4. The vital signs are stable and can cooperate with the examination. 5. Informed consent signed by the patient or legal representative. 2. Exclusion Criteria: 1. Cerebral infarction or cerebral hemorrhage caused by large vascular disease; And CTA/MRA of the head and neck showed great vessel stenosis (stenosis rate \> 50%). 2. Patients with secondary white matter lesions caused by poisoning, inflammation, tumor and other pathological changes. 3. Cognitive impairment and gait impairment caused by other causes (such as Alzheimer's disease, Parkinson's disease, depression, etc. 4. Patients with contraindications of magnetic resonance examination. 5. Illiterate or unable to cooperate with cognitive assessment due to severe hearing and visual impairment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zigong First People's Hospital Zigong Sichuan Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05715710 on ClinicalTrials.gov ↗ ← All trials in China